EBA
Eagle Bay Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.75M | Sell |
9,434
-48
| -0.5% | -$8.91K | 1.45% | 15 |
|
2025
Q1 | $1.99M | Sell |
9,482
-33
| -0.3% | -$6.91K | 1.68% | 14 |
|
2024
Q4 | $1.69M | Sell |
9,515
-206
| -2% | -$36.6K | 1.06% | 18 |
|
2024
Q3 | $1.92M | Buy |
9,721
+7
| +0.1% | +$1.38K | 0.74% | 28 |
|
2024
Q2 | $1.67M | Buy |
9,714
+378
| +4% | +$64.8K | 1.01% | 19 |
|
2024
Q1 | $1.7M | Sell |
9,336
-534
| -5% | -$97.2K | 1.07% | 19 |
|
2023
Q4 | $1.53M | Sell |
9,870
-385
| -4% | -$59.7K | 0.97% | 22 |
|
2023
Q3 | $1.53M | Buy |
10,255
+441
| +4% | +$65.7K | 0.71% | 31 |
|
2023
Q2 | $1.32M | Sell |
9,814
-22
| -0.2% | -$2.96K | 0.76% | 31 |
|
2023
Q1 | $1.57M | Sell |
9,836
-429
| -4% | -$68.4K | 0.86% | 26 |
|
2022
Q4 | $1.66M | Sell |
10,265
-1,233
| -11% | -$199K | 0.93% | 24 |
|
2022
Q3 | $1.54M | Sell |
11,498
-292
| -2% | -$39.2K | 0.95% | 21 |
|
2022
Q2 | $1.81M | Buy |
11,790
+329
| +3% | +$50.4K | 1.09% | 16 |
|
2022
Q1 | $1.86M | Buy |
11,461
+128
| +1% | +$20.8K | 1.52% | 13 |
|
2021
Q4 | $1.54M | Sell |
11,333
-2,476
| -18% | -$335K | 0.98% | 16 |
|
2021
Q3 | $1.49M | Buy |
13,809
+2,171
| +19% | +$234K | 0.84% | 19 |
|
2021
Q2 | $1.33M | Buy |
+11,638
| New | +$1.33M | 1.07% | 17 |
|